RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Kansas City, KS · +25 more sites
6 recruiting ulcerative colitis studies with a site in Kansas City, KS.
All trials in Kansas City, KS · All Ulcerative Colitis trials
Sponsor: Spyre Therapeutics, Inc.
Kansas City, KS · +25 more sites
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
Sponsor: Merck Sharp & Dohme LLC
Kansas City, KS · +10 more sites
Sponsor: Takeda
Kansas City, KS · +36 more sites
Sponsor: Boehringer Ingelheim
Kansas City, KS · +13 more sites
Sponsor: Sanofi
Kansas City, KS · +117 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.